Can ADCs broaden the treatment landscape of metastatic ER+/HER2− breast cancer resistant to CDK4/6 inhibition?

Detalles Bibliográficos
Autores principales: Van Baelen, Karen, Desmedt, Christine, Wildiers, Hans, Neven, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113101/
https://www.ncbi.nlm.nih.gov/pubmed/37082695
http://dx.doi.org/10.21037/atm-23-41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113101/
https://www.ncbi.nlm.nih.gov/pubmed/37082695
http://dx.doi.org/10.21037/atm-23-41

Ejemplares similares